Low cost, max effects? Korean firm Navipharm developing duo-strain products amid ‘pharmabiotics’ ambitions 14-Sep-2021 By Tingmin Koe South Korean firm Navipharm is focusing its R&D efforts on duo-strain probiotics products, after conducting research that appears to show that they are as efficacious, and more cost effective, as compared to multi-strain products.